Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norman Wolmark, MD
NSABP Foundation Inc
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope
Duarte, California, United States
- Smilow Cancer Hospital at Yale-New Haven
New Haven, Connecticut, United States
- Smilow Cancer Hospital Care Center at North Haven
North Haven, Connecticut, United States
- Uf Health Davis Cancer Pavilion and Shands Med Plaza
Gainesville, Florida, United States
- Uf Health Shands Cancer Hospital
Gainesville, Florida, United States
- Uf Health Shands Hospital
Gainesville, Florida, United States
- University of Florida
Gainesville, Florida, United States
- University of Florida Health Cancer Center at Orlando Health
Orlando, Florida, United States
- Centralia Oncology Clinic
Centralia, Illinois, United States
- Cancer Care Specialists of Central Illinois
Decatur, Illinois, United States
- Cancer Care Specialists of Central Illinois/crossroads Cancer Center
Effingham, Illinois, United States
- Cancer Care Specialists of Central Illinois-Swansea
Swansea, Illinois, United States
- Trinity Health Michigan
Ann Arbor, Michigan, United States
- University of Michigan
Ann Arbor, Michigan, United States
- St. Joseph Mercy-Brighton
Brighton, Michigan, United States
- St. Joseph Mercy-Canton
Canton, Michigan, United States
- St Joseph Mercy-Chelsea
Chelsea, Michigan, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2017
- Primary completion
- 18 Apr 2019
- Completion
- 9 Aug 2019
- Last update posted
- 5 Dec 2022
- Registered enrollment
- 33
- Registry id
- NCT03007407
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.